Biorestorative TherapiesBRTX

13F holders, Q3 2025 (September 30)
14holders −1
3new positions
4sold out
1famous investor
$1.44avg. 13F price*

At the end of Q3 2025, 14 institutions reported holding Biorestorative Therapies Inc. (BRTX) in their 13F filings, down 1 from Q2 2025. 3 opened new positions and 4 sold out. The largest holders were Citadel Advisors ($152K), Vanguard Group Inc. ($127K) and Geode Capital Management, LLC ($79K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Biorestorative Therapies Inc.
CUSIP
090655606
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q1 2024: 13Q1 2024Q2 2024: 13Q2 2024Q3 2024: 15Q3 2024Q4 2024: 15Q4 2024Q1 2025: 14Q1 2025Q2 2025: 15Q2 2025Q3 2025: 14Q3 2025Q4 2025: 13Q4 2025Q1 2026: 11Q1 2026Q2 2026: 21Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions3$153K
Exits4$82K

All 13F filers, Q2 2025 → Q3 2025: 181,942 shares bought and 49,820 shares sold, net +132,122 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 14 holders

Citadel Advisors 0.00% New 106,210 $152K
Vanguard Group Inc. 0.00% Add +198.6% 88,778 $127K
Geode Capital Management, LLC 0.00% Add +1.9% 55,269 $79K
Wealth Alliance, LLC 0.01% No change 40,000 $58K
StoneX Group Inc. 0.00% Reduce -0.8% 37,450 $54K
Virtu Financial LLC 0.00% Add +102.4% 24,351 $35K
State Street Corp. 0.00% No change 20,459 $29K
Tower Research Capital LLC (TRC) 0.00% Add +183.2% 3,619 $5K
Osaic Holdings, Inc. 0.00% No change 2,193 $4K
Wells Fargo & Company 0.00% New 1,000 $1K
SBI Securities Co., Ltd. 0.00% Add +18.0% 105 $152
Bank of America Corp. 0.00% No change 50 $73
TD Waterhouse Canada Inc. 0.00% No change 3 $4
Citigroup Inc. 0.00% New 1 $1

"% of holder's portfolio" is BRTX's weight in each manager's 13F, not the share of Biorestorative Therapies Inc. the manager owns.